[Influenza vaccination for elderly patients with neurological disease].
Elderly people have a high risk for influenza and the existence of central neurological disease is also considered to be a high risk factor for to causing pulmonary complications because of misswallowing. One hundred and forty one elderly patients (60 years or older) were observed. As control 243 cases were also inoculated with one dose of the same vaccine. Thirty-five out of the 243 control received a 2nd dose. After one vaccination the rise of HI titer (percentage of cases with > 40 and GMT) was good enough to be effective in both elderly patients and controls. No significant differences between elderly patients and the control group were observed. Booster effects by 2nd vaccination were not revealed. No serious side effects were noted in all cases throughout the study. In conclusion, influenza vaccine was well treated among the patients with neurological diseases.
Kaji
Masahide
M
Kurume University Medical Center, Department of Neurology.
Watanabe
Aya
A
Aizawa
Hisamichi
H
D000328:Adult; D000368:Aged; D005260:Female; D006801:Humans; D007252:Influenza Vaccines; D007251:Influenza, Human / Q000517:prevention & control*; D008297:Male; D008875:Middle Aged; D009422:Nervous System Diseases; D014611:Vaccination / Q000379:methods*
D007252:Influenza Vaccines